LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping
Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry
Daniel Chelsky, Caprion Proteomics Inc, speaking at Diagnostics & Biomarkers.
Webinar: Human Recombinant Antibodies as Positive Controls and Calibrators
Join this webinar to find out how we use the HuCAL® antibody library and phage display technology to generate custom recombinant antibodies as alternatives to human and animal sera.
Biomarkers to Predict Aggressive Prostate Cancer
Contributions of Mass Spectrometry in the Diagnosis and Management of Hypothalamic–pituitary–adrenal Axis Disorders
Gregori Casals, Hospital Clínic Barcelona, speaking at Clinical Applications of Mass Spectrometry.
History and Development of High Resolution Mass Spectrometry for Infectious Disease Diagnostics
Haroun Shah, Public Health England, speaking at Clinical Applications of Mass Spectrometry.
Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology
Andreas Jeromin, Atlantic Biomarkers, speaking at Diagnostics & Biomarkers 2015.
Diagnosis of Disorders Affecting Steroid Synthesis and Metabolism by Mass Spectrometry
Josep Marcos del Aguila, IMIM, speaking at Clinical Applications of Mass Spectrometry 2014.
A Novel Vertically-Integrated Platform for the Discovery and Molecular Characterization of Lung Cancer Stem Cells
Raj Batra, University of California Los Angeles, speaking at Diagnostics & Biomarkers 2015.
Evidence Based Guidelines for the Pre-analytical Phase of RNA Testing in Blood Samples
Francesca Malentacchi, University of Florence, Speaking at Advances in qPCR and dPCR 2014
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 93|